Ticker Details
Cardiff Oncology, Inc.
IPO Date:	August 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$121.7M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 4.08%
Avg Daily Range (30 D):	$0.04 | 2.51%
Avg Daily Range (90 D):	$0.05 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	.83M
Avg Daily Volume (90 D):	.95M

Trade Size
Avg Trade Size (Sh.):	178
Avg Trade Size (Sh.) (30 D):	203
Avg Trade Size (Sh.) (90 D):	214

Institutional Trades
Total Institutional Trades:	177
Avg Institutional Trade:	$2.01M
Avg Institutional Trade (30 D):	$.63M
Avg Institutional Trade (90 D):	$.63M
Avg Institutional Trade Volume:	.26M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.1M
Avg Closing Trade (30 D):	$.63M
Avg Closing Trade (90 D):	$.63M
Avg Closing Volume:	376.13K

News

May 21, 2026 @ 9:00 PM Cardiff Oncology Announces Webcast to Discuss Upda... Source: Cardiff Oncology, Inc.

Apr 21, 2026 @ 2:00 PM Cardiff Oncology to Present Updated Phase 2 Data o... Source: Na

Mar 19, 2026 @ 11:00 AM Cardiff Oncology to Present Preclinical Data with ... Source: Na

Nov 24, 2025 @ 12:00 PM Cardiff Oncology to Present at the Piper Sandler 3... Source: Cardiff Oncology, Inc.

Nov 12, 2025 @ 6:00 PM KRAS Inhibitors Market to Witness Explosive Growth... Source: Delveinsight

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.18	$-.17	$-.21
Diluted EPS	$-.18	$-.17	$-.21
Revenue	$.04M	$.12M	$.12M
Gross Profit
Net Income / Loss	$-12.35M	$-11.26M	$-13.94M
Operating Income / Loss	$-12.85M	$-11.97M	$-14.78M
Cost of Revenue
Net Cash Flow	$-8.93M	$-.65M	$-13.31M
PE Ratio

Splits
Feb 20, 2019	1:6
Jun 04, 2018	1:12
May 30, 2012	1:6